{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T14:15:28Z","timestamp":1683814528463},"reference-count":47,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.gofs.2019.03.002","type":"journal-article","created":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T16:57:56Z","timestamp":1552064276000},"page":"451-457","source":"Crossref","is-referenced-by-count":1,"title":["Pr\u00e9vention des infections g\u00e9nitales hautes postop\u00e9ratoires ou associ\u00e9es aux soins. RPC infections g\u00e9nitales hautes CNGOF et SPILF"],"prefix":"10.1016","volume":"47","author":[{"given":"B.","family":"Castan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.gofs.2019.03.002_bib0005","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijgo.2015.11.028","article-title":"Updated French guidelines for diagnosis and management of pelvic inflammatory disease","volume":"134","author":"Brun","year":"2016","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.gofs.2019.03.002_bib0015","unstructured":"SOGC. Antibiotic prophylaxis in gynaecologic procedures. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22472341. Consult\u00e9 le 31\/07\/2018."},{"key":"10.1016\/j.gofs.2019.03.002_bib0020","unstructured":"SOGC. No. 247-Antibiotic Prophylaxis in Obstetric Procedures https:\/\/www.jogc.com\/article\/S1701-2163(17)30586-8\/pdf. Consult\u00e9 le 31\/07\/2018."},{"issue":"5","key":"10.1016\/j.gofs.2019.03.002_bib0025","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1479-828X.2012.01460.x","article-title":"Antibiotic prophylaxis in obstetric and gynaecological procedures: a review","volume":"52","author":"Clifford","year":"2012","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.gofs.2019.03.002_bib0030","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa0809146","article-title":"Rates of serious infection after changes in regimen for medical abortion","volume":"361","author":"Fjesstad","year":"2009","journal-title":"N Eng J Med"},{"issue":"2","key":"10.1016\/j.gofs.2019.03.002_bib0035","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1056\/NEJMc1614626","article-title":"Adjunctive azithromycin prophylaxis for cesarean delivery","volume":"376","author":"Greig","year":"2017","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.gofs.2019.03.002_bib0040","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/BF01653540","article-title":"Principles of antimicrobial prophylaxis","volume":"6","author":"Burdon","year":"1982","journal-title":"World J Surg"},{"key":"10.1016\/j.gofs.2019.03.002_bib0045","unstructured":"ACOG practice bulletin No. 104: antibiotic prophylaxis for gynecologic procedures. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19384149. Consult\u00e9 le 31\/07\/2018."},{"key":"10.1016\/j.gofs.2019.03.002_bib0050","unstructured":"RCOG. Antibiotics for retained products of conception https:\/\/www.rcog.org.uk\/en\/guidelines-researchservices\/guidelines\/antibiotics-for-retained-products-of-conception-query-bank. Consult\u00e9 le 31\/07\/2018."},{"key":"10.1016\/j.gofs.2019.03.002_bib0055","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines.2010","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.gofs.2019.03.002_bib0060","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/AOG.0b013e3181e92c54","article-title":"Pelvic inflammatory disease","volume":"116","author":"Soper","year":"2010","journal-title":"Obstet and Gynecol"},{"issue":"5","key":"10.1016\/j.gofs.2019.03.002_bib0075","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1177\/0956462415618837","article-title":"2015\u00a0European guideline on the management of Chlamydia trachomatis infections","volume":"27","author":"Lanjouw","year":"2016","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.gofs.2019.03.002_bib0080","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/sextrans-2011-050385","article-title":"Azithromycin antimicrobial resistance and genital Chlamydia trachomatis infection: duration of therapy may be the key to improving efficacy","volume":"88","author":"Horner","year":"2012","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.gofs.2019.03.002_bib0085","doi-asserted-by":"crossref","first-page":"730","DOI":"10.2340\/00015555-2108","article-title":"Five-day azithromycin treatment regimen for Mycoplasma genitalium infection also effectively eradicates Chlamydia trachomatis","volume":"95","author":"Unemo","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.gofs.2019.03.002_bib0090","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0002-9378(96)70324-1","article-title":"Endometrial ablation: a series of 568\u00a0patients treated over 11-year period","volume":"174","author":"Baggish","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gofs.2019.03.002_bib0095","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1086\/428290","article-title":"Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report","volume":"191","author":"Wang","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.gofs.2019.03.002_bib0100","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/QCO.0000000000000030","article-title":"Time to manage Mycoplasma genitalium as an STI: but not with azithromycin 1g","volume":"27","author":"Horner","year":"2014","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.gofs.2019.03.002_bib0105","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/cid\/ciu220","article-title":"Azithromycin versus doxycycline for the treatment of genital Chlamydia infection: a meta-analysis of randomized controlled trials","volume":"59","author":"Kong","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.gofs.2019.03.002_bib0110","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1701-2163(15)30636-8","article-title":"Infectious disease committee. Best practices to minimize risk of infection with intrauterine device insertion","volume":"36","author":"Caddy","year":"2014","journal-title":"J Obstet Gynaecol Can"},{"issue":"2","key":"10.1016\/j.gofs.2019.03.002_bib0115","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1056\/NEJMc1614626","article-title":"Adjunctive azithromycin prophylaxis for cesarean delivery","volume":"376","author":"Ragusa","year":"2017","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.gofs.2019.03.002_bib0120","first-page":"182","article-title":"Adjunctive azithromycin prophylaxis for cesarean delivery","volume":"376","author":"Tita","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gofs.2019.03.002_bib0125","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD011876.pub2","article-title":"Routes of administration of antibiotic prophylaxis for preventing infection after caesarean section","author":"Nabhan","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.gofs.2019.03.002_bib0130","article-title":"Timing of antibiotic prophylaxis in elective caesarean delivery: a multi-center randomized controlled trial and meta-analysis","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.gofs.2019.03.002_bib0135","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/s12884-017-1526-y","article-title":"A randomized controlled double blind trial comparing the effects of the prophylactic antibiotic, Cefazolin, administered at caesarean delivery at two different timings (before skin incision and after cord clamping) on both the mother and newborn","volume":"17","author":"Jyothirmayi","year":"2017","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.gofs.2019.03.002_bib0140","unstructured":"ASHP\/IDSA Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery http:\/\/www.idsociety.org\/Guidelines\/Patient_Care\/IDSA_Practice_Guidelines\/Antimicrobial_Agent_Use\/Antimicrobial_Prophylaxis_for_Surgery. Consult\u00e9 le 31\/07\/2018."},{"key":"10.1016\/j.gofs.2019.03.002_bib0145","unstructured":"Antibiotic prophylaxis for first trimester induced abortion. The Cochrane library 2012. Issue 3. https:\/\/www.cochrane.org\/CD005217\/FERTILREG_antibiotic-prophylaxis-for-first-trimester-induced-abortion. Consult\u00e9 le 31\/07\/2018."},{"key":"10.1016\/j.gofs.2019.03.002_bib0150","unstructured":"Prophylactic antibiotics for transcervical intrauterine procedures. The Cochrane library 2013. Issue 5. http:\/\/cochranelibrarywiley.com\/doi\/10.1002\/14651858.CD005637.pub3\/full. Consult\u00e9 le 31\/07\/2018."},{"key":"10.1016\/j.gofs.2019.03.002_bib0155","unstructured":"Mifeprex (mifepristone) Adverse Events Report as of April 2011. US Food and drug Administration.2007. http:\/\/wayback.archive-it.org\/7993\/20161024033523\/http:\/\/www.fda.gov\/downloads\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/UCM263353.pdf. Consult\u00e9 le 31\/07\/2018."},{"key":"10.1016\/j.gofs.2019.03.002_bib0160","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1056\/NEJMoa051620","article-title":"Fatal toxic shock syndrome associated with Clostridium sordellii after medical abortion","volume":"353","author":"Fischer","year":"2005","journal-title":"N Eng J Med"},{"key":"10.1016\/j.gofs.2019.03.002_bib0165","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/0029-7844(94)00326-9","article-title":"Six hundred endometrial laser ablations","volume":"85","author":"Gary","year":"1995","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gofs.2019.03.002_bib0170","unstructured":"Strat\u00e9gie de d\u00e9pistages des infections \u00e0 Chlamydia trachomatis. Feuille de route. HAS. https:\/\/www.has-sante.fr\/portail\/upload\/docs\/application\/pdf\/2016-08\/feuille_de_route_strategie_de_depistage_des_infections_a_chlamydia_trachomatis.pdf. Consult\u00e9 le 31\/07\/2018."},{"key":"10.1016\/j.gofs.2019.03.002_bib0175","unstructured":"Recommandations diagno stiques et th\u00e9rapeutiques pour les Maladies Infectieuses transmissibles, 2016. Soci\u00e9t\u00e9 Fran\u00e7aise de Dermatologie. http:\/\/www.sfdermato.org\/media\/image\/upload-editor\/files\/Guidelines%202016(1).pdf. Consult\u00e9 le 31\/07\/2018."},{"issue":"4","key":"10.1016\/j.gofs.2019.03.002_bib0180","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0015-0282(01)03252-6","article-title":"Postoperative infection and surgical hysteroscopy","volume":"77","author":"Agostini","year":"2002","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.gofs.2019.03.002_bib0185","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/AOG.0b013e318227f05e","article-title":"ACOG Practice Bulletin No. 121: long-acting reversible contraception: implants and intrauterine devices","volume":"118","author":"American College of Obstetricians and Gynecologists","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.gofs.2019.03.002_bib0190","first-page":"445","article-title":"Intrauterine devices: an update","volume":"89","author":"Hardeman","year":"2014","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.gofs.2019.03.002_bib0200","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1097\/AOG.0b013e318273364c","article-title":"Neisseria gonorrhea and Clamydia trachomatis screening at intrauterine device insertion and pelvic inflammatory disease","volume":"120","author":"Sufrin","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gofs.2019.03.002_bib0205","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/0140-6736(92)91904-M","article-title":"Intrauterine devices and pelvic inflammatory disease","volume":"339","author":"Farley","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.gofs.2019.03.002_bib0210","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1471-0528.1990.tb01828.x","article-title":"Preventing IUCD-related pelvic infection: the efficacy of prophylactic doxycycline at insertion","volume":"97","author":"Sinei","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.gofs.2019.03.002_bib0215","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF01850718","article-title":"Prevention of IUD: the efficacy of prophylactic doxycycline at insertion","volume":"7","author":"Lidipo","year":"1991","journal-title":"Adv Contracept"},{"key":"10.1016\/j.gofs.2019.03.002_bib0220","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1017\/S0195941700015241","article-title":"CDC definitions of nosocomial surgical site infections, 1992; A modification of CDC definitions of surgical wound infections","volume":"13","author":"Horan","year":"1992","journal-title":"Infection Control Hosp Epidemiol"},{"key":"10.1016\/j.gofs.2019.03.002_bib0225","series-title":"Long-acting reversible contraception: The effective and appropriate use of long-acting reversible contraception","author":"National Collaborating Centre for Women's and children's Health (UK)","year":"2005"},{"key":"10.1016\/j.gofs.2019.03.002_bib0230","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0015-0282(16)44712-6","article-title":"Febrile morbidity following hysterosalpingography: identification of risk factor and recommandations for prophylaxis","volume":"33","author":"Stupf","year":"1980","journal-title":"Fertil Steril"},{"key":"10.1016\/j.gofs.2019.03.002_bib0235","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0002-9378(83)90438-6","article-title":"Prevention of acute pelvic inflammatory diseaseafter hysterosalpingography: efficacy of doxycycline prophylaxis","volume":"147","author":"Pittaway","year":"1983","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.gofs.2019.03.002_bib0240","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/AOG.0000000000000789","article-title":"Cefazolin prophylaxis in obese women undergoing cesarean delivery: a randomized controlled trial","volume":"125","author":"Maggio","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.gofs.2019.03.002_bib0245","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ajog.2015.06.034","article-title":"Pharmacokinetics of cefazolin prophylaxis in obese gravidae at time of cesarean delivery","volume":"213","author":"Young","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gofs.2019.03.002_bib0250","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.jgyn.2012.09.021","article-title":"Antibioprophylaxie et interventions endo-ut\u00e9rines","volume":"41","author":"Shojai","year":"2012","journal-title":"J Gynecol Obst Biol Reprod"},{"issue":"12","key":"10.1016\/j.gofs.2019.03.002_bib0255","first-page":"762","article-title":"PURLs: does azithromycin have a role in cesarean sections?","volume":"66","author":"Castelli","year":"2017","journal-title":"J Fam Pract"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246871891930100X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246871891930100X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T16:56:55Z","timestamp":1559667415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S246871891930100X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S246871891930100X"],"URL":"https:\/\/doi.org\/10.1016\/j.gofs.2019.03.002","relation":{},"ISSN":["2468-7189"],"issn-type":[{"value":"2468-7189","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]}}}